financetom
Business
financetom
/
Business
/
Century Casinos beats Q2 revenue estimates, announces strategic review
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Century Casinos beats Q2 revenue estimates, announces strategic review
Aug 7, 2025 3:46 AM

Overview

* Century Casinos ( CNTY ) Q2 net operating revenue rises 3%, beating analyst expectations

* Earnings from operations up 16%, adjusted EBITDAR increases 10%

* Co initiates strategic review to enhance shareholder value

* This could include sale of the company among other alternatives to be reviewed

Outlook

* Company to launch sports betting in Missouri in Q4 2025

* Century Casinos to open new casino in Poland in Q4 2025

Result Drivers

* CARUTHERSVILLE OPENING - New casino and hotel in Caruthersville, Missouri boosts net operating revenue by 26% and Adjusted EBITDAR by 31%

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $150.80 $149.20

Revenue mln mln (4

Analysts

)

Q2 $30.30

Adjusted mln

EBITDA

Q2 $16.60

Earnings mln

from

Operatio

ns

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the casinos & gaming peer group is "buy"

* Wall Street's median 12-month price target for Century Casinos Inc ( CNTY ) is $4.00, about 44.8% above its August 6 closing price of $2.21

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Sep 27, 2024
On Thursday, the FDA approved Bristol Myers Squibb ( BMY ) & Co’s Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. Bristol-Myers added the treatment via Karuna Therapeutics deal for $330 per share in cash for a total equity value of $14 billion. Cobenfy represents the first new class of medicine in several decades and introduces...
Market Chatter: Apple Rethinking Strategy to Release Movies in Theaters
Market Chatter: Apple Rethinking Strategy to Release Movies in Theaters
Sep 27, 2024
07:01 AM EDT, 09/27/2024 (MT Newswires) -- Apple ( AAPL ) is rethinking its strategy to release movies in theaters and planning to make roughly a dozen movies annually, Bloomberg reported Friday, citing unnamed people familiar with the matter. The firm's commitment to spend $1 billion a year on movies will not change, but Apple's ( AAPL ) approach towards...
EU privacy regulator fines Meta 91 million euros over password storage
EU privacy regulator fines Meta 91 million euros over password storage
Sep 27, 2024
DUBLIN (Reuters) - The lead European Union privacy regulator fined social media giant Meta 91 million euros ($101.5 million) on Friday for inadvertently storing some users' passwords without protection or encryption. The inquiry was opened five years ago after Meta notified Ireland's Data Protection Commission (DPC) that it had stored some passwords in 'plaintext'. Meta publicly acknowledged the incident at...
Ault Disruptive Technologies to Redeem Shares, Cease Operations
Ault Disruptive Technologies to Redeem Shares, Cease Operations
Sep 27, 2024
07:11 AM EDT, 09/27/2024 (MT Newswires) -- Ault Disruptive Technologies Corporation ( ADRT ) , a publicly-traded special purpose acquisition company, said Friday its board of directors has decided to redeem all outstanding shares of common stock as the company is unable to complete an initial business combination within the deadline of Dec. 20 as specified in its amended certificate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved